Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08)

Name: Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-10-01

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) (French, HTML) HTML
Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) (English, HTML) HTML

Related open data

Health Canada